4//SEC Filing
HSU ERIC C 4
Accession 0001213900-23-018869
CIK 0001728328other
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 3:45 PM ET
Size
5.4 KB
Accession
0001213900-23-018869
Insider Transaction Report
Form 4
HSU ERIC C
Sr VP, Pre-Clinical Res/Dev
Transactions
- Expiration (Short)
Employee Stock Option (Expiration)
2023-03-08−545→ 8,333 totalExercise: $927.64From: 2018-03-08Exp: 2023-03-08→ Common shares (545 underlying)
Footnotes (1)
- [F1]Converted from the Canadian dollar exercise price of C$1,278.75 using an exchange rate of C$1.3785 = $US1.00
Documents
Issuer
InMed Pharmaceuticals Inc.
CIK 0001728328
Entity typeother
Related Parties
1- filerCIK 0001817867
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 3:45 PM ET
- Size
- 5.4 KB